Omitting radiotherapy in LUMINA-like breast cancer after breast conserving surgery: 10-year results of a population-based cohort study
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf355 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Oncologist, 2025. Verfasst von Shenkangle Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental, Neoplasm Recurrence, Local. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Medical and Health Science and Technology of Zhejiang Province.
Abstract (Originalsprache)
Background
Recently, the LUMINA trial reported 5-year results of omitting radiotherapy in a low-risk cohort after breast-conserving surgery (BCS). This study aimed to validate their 5-year results and investigate 10-year outcomes of patients satisfying their criteria in a population-based cohort. Materials and Methods A total of 28 185 eligible patients were identified from the Surveillance, Epidemiology and End Results (SEER) database to establish SEER-LUMINA cohort. The Kaplan–Meier method was employed to estimate recurrence incidence and survival outcomes. Matched cohorts were generated using propensity score matching (PSM). The Cox proportional hazards model was used to generate hazard ratios.
Results
A total of 6808 patients of the 28 185 did not receive radiotherapy while 21 377 underwent postoperative radiotherapy. After PSM, each group had 5954 patients, revealing significant differences in local recurrence incidence (no-radiotherapy group 0.65% at 5 years and 3.68% at 10 years vs radiotherapy group 0.14% at 5 years and 1.54% at 10 years, P < .001), breast cancer-specific survival (BCSS) (no-radiotherapy group 98.51% at 5 years and 96.11% at 10 years vs radiotherapy group 99.05% at 5 years and 96.34% at 10 years, P = .028). No difference was observed in BCSS between the 2 groups for SEER-LUMINA patients with tumor ≤1.4 cm (the optimal tumor size cutoff value for BCSS) (P = .099).
Conclusion
Incidence, whether 5-year or 10-year recurrence, was lower than 5% in the SEER-LUMINA cohort. Radiotherapy following BCS reduced the local recurrence statistically significantly for those patients, but the clinical impact of this reduction was modest. Radiotherapy did not result in a difference in BCSS for SEER-LUMINA patients with tumors ≤1.4 cm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China.
- Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, Zhejiang 310016, China.
- Department of Radiation Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China.
- Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang Province, China.
- The First Affiliated Hospital of Zhejiang, Chinese Medical University, Hangzhou, Zhejiang 310014, China.
- Department of General Surgery, The Ninth People's Hospital of Hangzhou, Hangzhou, Zhejiang 310014, China.
ORCID-Profile: Shenkangle Wang, Jichun Zhou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Medical and Health Science and Technology of Zhejiang Province
- Zheng Shu Medical Elite Scholarship Fund
Zitieren
APA
Wang, S., Zhu, Z., Cui, B., Luo, M., Lin, X., Guo, Z., Wu, Q., Wang, L., Sun, X., & Zhou, J. (2025). Omitting radiotherapy in LUMINA-like breast cancer after breast conserving surgery: 10-year results of a population-based cohort study. The Oncologist. https://doi.org/10.1093/oncolo/oyaf355
Vancouver
Wang S, Zhu Z, Cui B, Luo M, Lin X, Guo Z, et al. Omitting radiotherapy in LUMINA-like breast cancer after breast conserving surgery: 10-year results of a population-based cohort study. The Oncologist. 2025. doi:10.1093/oncolo/oyaf355
BibTeX
@article{Wang2025,
author = {Wang, Shenkangle and Zhu, Ziyu and Cui, Binbin and Luo, Mingpeng and Lin, Xixi and Guo, Zijie and Wu, Qingliang and Wang, Linbo and Sun, Xiaonan and Zhou, Jichun},
title = {Omitting radiotherapy in LUMINA-like breast cancer after breast conserving surgery: 10-year results of a population-based cohort study},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf355}
}
EUVIMED